teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - Želodne neoplazme - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
premovir 125 mg tablete
berlin-chemie ag - brivudin - tableta - brivudin 125 mg / 1 tableta - brivudin
premovir 125 mg tablete
berlin-chemie ag - brivudin - tableta - brivudin 125 mg / 1 tableta - brivudin
kapecitabin sandoz 150 mg filmsko obložene tablete
sandoz d.d. - kapecitabin - filmsko obložena tableta - kapecitabin 150 mg / 1 tableta - kapecitabin
kapecitabin sandoz 500 mg filmsko obložene tablete
sandoz d.d. - kapecitabin - filmsko obložena tableta - kapecitabin 500 mg / 1 tableta - kapecitabin
marevan 3 mg tablete
orion corporation - natrijev varfarinat - tableta - natrijev varfarinat 3 mg / 1 tableta - varfarin
kapecitabin sandoz 500 mg filmsko obložene tablete
sandoz d.d. - kapecitabin - filmsko obložena tableta - kapecitabin 500 mg / 1 tableta - kapecitabin
marevan 3 mg tablete
orion corporation - natrijev varfarinat - tableta - natrijev varfarinat 3 mg / 1 tableta - varfarin
marevan 5 mg tablete
tableta - varfarin
marevan 5 mg tablete
tableta - varfarin